reference/16696623

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16696623

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	41
issn	0098-7484
issueIdentifier	18
pageRange	2134-41
publicationName	JAMA
startingPage	2134
bibliographicCitation	Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Saito Y; Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA. 2008 Nov 12;300(18):2134–41. doi: 10.1001/jama.2008.623. PMID: 18997198.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97b25282d8d4a22f3ddd3c4542d3dcc0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc2ccf6ef9f324461535d4ca4d6cb9e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_274c44c9b9d61e88c5fe6fb46837ddca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a9cfe9a88fae2596c570c7ac0263f93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42897206ef5a21611f5ceeb5f14ee178 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56a63fc6d8c4283d2085a4719303eab3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd5d99f955d0f688401f222047245a82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7444858d3047a843762b37ccc87b5c69 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58c3cc95a5ad28500c9bf89cb7a12884
date	2008-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/18997198 https://doi.org/10.1001/jama.2008.623
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5346 https://portal.issn.org/resource/ISSN/0098-7484
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial
discusses	http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0017012
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D010975Q000627 http://id.nlm.nih.gov/mesh/D001241Q000627 http://id.nlm.nih.gov/mesh/D050197Q000517 http://id.nlm.nih.gov/mesh/D003925Q000517
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D001241Q000008 http://id.nlm.nih.gov/mesh/D003925Q000209 http://id.nlm.nih.gov/mesh/D003924Q000150 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D002318Q000517 http://id.nlm.nih.gov/mesh/D002318Q000453 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D002318Q000209 http://id.nlm.nih.gov/mesh/D010975Q000008 http://id.nlm.nih.gov/mesh/D050197Q000453 http://id.nlm.nih.gov/mesh/D050197Q000209 http://id.nlm.nih.gov/mesh/D003925Q000453
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6749 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9997 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7970 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10898 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11310 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7224

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695

Total number of triples: 63.